BeStock  

Agilon Health AGL

US equityMarket cap rank #2869Medical Care Facilities
$90.24 +$0.74 (+0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $90.22 -0.02%
Open$89.62
Prev close$89.50
Day range$85.77 – $90.41
Volume266.3K
Market cap$1.52B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership112.2%+15.04 pts vs. prior quarter
Institutions holding235+15 vs. prior quarter
Insider trades (recent)25 buys / 25 sellsBalanced
Short interest5.04% of floatDays to cover 4.7 · as of 30 Oct 2026
Short-sale volume share22.4%5-day average of daily volume

Short-sale volume as % of daily volume

15%21%28%34%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$2.22M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

+$2.1MSuper+$121.6KBig−$26.4KMid+$3.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 65.4% of shares outstanding.

Largest holders

  • Clayton, Dubilier & Rice, LLC23.82%
  • Morgan Stanley12.49%
  • Morgan Stanley Investment Management Inc.12.49%
  • North Peak Capital Management, LLC8.84%
  • BlackRock7.80%
  • AQR Capital Management4.02%
  • The Goldman Sachs Group, Inc.3.61%
  • Vanguard Capital Management, LLC3.11%

By investor type

  • Mutual Fund40.85%
  • Hedge Fund27.56%
  • VC/PE Fund24.44%
  • Public Company17.21%
  • Individual/Insider2.25%
  • Insurance Company0.77%
  • Family Office/Trust0.54%
  • Private Company0.47%

Reported short interest has fallen from 5.83% to 5.04% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +162,733 7.8%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +110,031 1.6%
Morgan Stanley Public Company 2026/Q3 +86,750 12.5%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +86,750 12.5%
FMR Mutual Fund 2026/Q3 +74,861 0.5%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +52,136 1.1%
Rhenman & Partners Asset Management AB Hedge Fund 2026/Q3 +47,924 0.3%
State Street Global Advisors Mutual Fund 2026/Q3 +46,031 1.9%
Barclays PLC Public Company 2026/Q3 +42,268 0.3%
Amundi Asset Management Mutual Fund 2026/Q3 +27,254 0.6%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +110,070 0.8%
Marshall Wace LLP Hedge Fund 2026/Q3 +468,293 2.8%
Durable Capital Partners, LP Hedge Fund 2026/Q3 +440,642 2.6%
BlackRock Mutual Fund 2026/Q3 +273,356 6.8%
Jane Street Group, LLC Private Company 2026/Q3 +258,280 1.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
15 Aug 2026 Timothy Gertsch Chief Accounting Officer Sale to Issuer -17 $96.90 14,152
31 Jul 2026 Denise Zamore Chief Legal & People Officer and Secretary Sale to Issuer -37 $91.61 66,075
30 Jun 2026 Jeffrey Schwaneke Chief Financial Officer Sale to Issuer -2,311 $111.74 18,808
1 Jun 2026 Ronald Williams Chairperson Other Acquisition +2,133 – 2,133
1 Jun 2026 Sharad Mansukani Independent Director Other Acquisition +2,133 – 2,133
1 Jun 2026 Silvana Battaglia Independent Director Other Acquisition +2,133 – 2,133
1 Jun 2026 Diana McKenzie Independent Director Other Acquisition +2,133 – 2,133
1 Jun 2026 Karen McLoughlin Independent Director Other Acquisition +2,133 – 2,133
1 Jun 2026 John Wulf Independent Director Other Acquisition +2,133 – 2,133
31 May 2026 Denise Zamore Chief Legal & People Officer and Secretary Sale to Issuer -485 $92.54 66,112
23 May 2026 Timothy Gertsch Chief Accounting Officer Sale to Issuer -8 $86.39 14,169
6 May 2026 Timothy O’Rourke Chief Executive Officer Other Acquisition +120,000 – 120,000
6 May 2026 Timothy O’Rourke Chief Executive Officer Other Acquisition +200,000 – 200,000
14 Apr 2026 Girish Venkatachaliah Advisor Sale to Issuer -426 $26.88 4,506
14 Apr 2026 Benjamin Shaker President Sale to Issuer -675 $26.88 37,269
14 Apr 2026 Denise Zamore Chief Legal & People Officer and Secretary Sale to Issuer -240 $26.88 66,597
14 Apr 2026 Timothy Gertsch Chief Accounting Officer Sale to Issuer -147 $26.88 14,177
31 Mar 2026 Jeffrey Schwaneke Chief Financial Officer Sale to Issuer -1,662 $9.75 12,760
31 Mar 2026 Jeffrey Schwaneke Chief Financial Officer Other Acquisition +75,000 – 128,474
31 Mar 2026 Girish Venkatachaliah Advisor Sale to Issuer -480 $9.75 3,484

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 846,737 5.0% 4.7
15 Oct 2026 899,148 5.4% 4.6
30 Sep 2026 1,008,702 6.0% 3.8
15 Sep 2026 1,050,591 6.3% 6.2
31 Aug 2026 1,080,524 6.4% 4.6
14 Aug 2026 978,825 5.8% 2.0

Discussion

No comments yet — be the first to weigh in on AGL.

Sign in to join the discussion.

Scroll to Top